Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) was up 1.1% during mid-day trading on Thursday . The stock traded as high as $1.99 and last traded at $1.97. Approximately 5,721 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 842,200 shares. The stock had previously closed at $1.95.
Ampliphi Biosciences Trading Up 1.1 %
Ampliphi Biosciences Company Profile
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
See Also
- Five stocks we like better than Ampliphi Biosciences
- Investing in Travel Stocks Benefits
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What is the S&P/TSX Index?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
